Article Information
History
- April 9, 2023.
Article Versions
- Version 1 (April 6, 2023 - 19:13).
- Version 2 (April 8, 2023 - 07:32).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Daichi Yamasoba1,2,#,
- Keiya Uriu1,3,#,
- Arnon Plianchaisuk1,#,
- Yusuke Kosugi1,3,#,
- Lin Pan1,4,#,
- Jiri Zahradnik5,
- The Genotype to Phenotype Japan (G2P-Japan) Consortium,
- Jumpei Ito1,6 and
- Kei Sato1,3,4,6,7,8,9,*
- 1Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- 2Faculty of Medicine, Kobe University, Kobe, Japan
- 3Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- 4Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan
- 5First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia
- 6International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- 7International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- 8Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan
- 9CREST, Japan Science and Technology Agency, Kawaguchi, Japan
- ↵*Correspondence: KeiSato{at}g.ecc.u-tokyo.ac.jp (Kei Sato)
↵# Contributed equally to this study.
Posted April 09, 2023.
